Hikal Ltd.

NSE: HIKAL | BSE: 524735 | ISIN: INE475B01022 | Industry: Pharmaceuticals
| Expensive Star
401.2000 1.75 (0.44%)
NSE Apr 01, 2025 15:31 PM
Volume: 103.0K
 

logo
Hikal Ltd.
22 Jun 2020
401.20
0.44%
BP Wealth
revenues. EBIT margin of Crop protection segment improved by 302bps (YoY) with ~46% contribution Target Price (INR) to overall EBIT. Pharmaceutical segment EBIT margin contracted by 45bps with ~54% contribution to overall EBIT. PAT came below our estimate at INR245mn (est INR329mn) dragged by operationally weak performance and higher tax expenses (35.1% vs 30.8%). On RM Sourcing from China: Hikal...
Hikal Ltd. has gained 51.37% in the last 1 Year
More from Hikal Ltd.
Recommended